"Antimanic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that are used to treat bipolar disorders or mania associated with other affective disorders.
| Descriptor ID |
D018692
|
| MeSH Number(s) |
D27.505.696.277.950.025 D27.505.954.427.210.950.025 D27.505.954.427.700.872.025
|
| Concept/Terms |
Antimanic Agents- Antimanic Agents
- Agents, Antimanic
- Antimanic Drugs
- Drugs, Antimanic
- Antimanics
Antimanic Effect- Antimanic Effect
- Effect, Antimanic
- Antimanic Effects
- Effects, Antimanic
|
Below are MeSH descriptors whose meaning is more general than "Antimanic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antimanic Agents".
This graph shows the total number of publications written about "Antimanic Agents" by people in this website by year, and whether "Antimanic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 10 | 4 | 14 |
| 2018 | 4 | 4 | 8 |
| 2019 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Antimanic Agents" by people in Profiles.
-
Lithium and Therapeutic Targeting of GSK-3. Cells. 2021 01 28; 10(2).
-
Lithium Intoxication in COVID-19: A Case Report. Psychiatr Danub. 2021; 33(2):248-249.
-
Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective. Prim Care Companion CNS Disord. 2020 06 18; 22(3).
-
Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid. Med Hypotheses. 2020 10; 143:109891.
-
Treatment of the obsessive-compulsive and bipolar disorders comorbidity: pharmacodynamic and pharmacokinetic evaluation. Expert Opin Drug Metab Toxicol. 2019 Aug; 15(8):619-631.
-
Conventional mood stabilizers and/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure. J Affect Disord. 2019 10 01; 257:412-420.
-
Current status and progress of electroencephalogram study in patients with bipolar disorder. Minerva Med. 2020 12; 111(6):613-614.
-
Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review. J Affect Disord. 2019 09 01; 256:433-440.
-
Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review. J Affect Disord. 2019 Apr 15; 249:15-19.
-
Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study. Hum Psychopharmacol. 2018 11; 33(6):e2676.